We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

GE May Sell Spacelabs to Meet Concerns of European Regulators

By HospiMedica staff writers
Posted on 31 Jul 2003
In order to get regulatory approval from the European Commission (EC) for its proposed US$2.3 billion acquisition of Instrumentarium (Helsinki, Finland), GE Medical Systems (Waukesha, WI, USA) is rumored to be considering the sale of Spacelabs (Bothell, WA, USA), a division of Instrumentarium.

Spacelabs was acquired by Instrumentarium in July 2002. The company makes and markets products for emergency and critical care, including monitoring and anesthesia equipment, as well as perioperative, neonatal, and obstetrical products. In 2002, the company had total revenues of $242 million.

GE is a major global supplier of medical imaging systems. The company's 2001 sales were $8 billion. By 2005, GE is aiming for sales to grow to about $15 million.

The European Commission has voiced its concerns that once combined, GE and Instrumentarium would have a large share of patient monitoring devices and imaging equipment used in hospitals and might be able to squeeze out smaller suppliers. The deadline for any proposals from GE is in mid-August. US regulators have not yet approved the deal, either.





Related Links:
Instrumentarium
GE Medical Systems
Spacelabs
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Patient Preoperative Skin Preparation
BD ChloraPrep
Tourniquet System
heidi– mein Tourniquet

Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more